Technical Articles

CDK2 binds to different cyclins (such as Cyclin E and Cyclin A) to form active complexes that drive the transition of key cell cycle checkpoints. During the transition from G1 phase to S phase, the CDK2-Cyclin E complex plays a critical role. It phosphorylates a series of substrates, such as the retinoblastoma protein (Rb), releasing the transcription factor E2F, thereby initiating the transcription of DNA replication-related genes and promoting the cell's entry into S phase for DNA synthesis.

Kinases play a central role in cellular signal transduction, metabolic regulation, and the development of various diseases. Research on the regulatory mechanisms of kinase activity and the screening of inhibitors are key aspects of modern drug development.

In the field of biomedical research, kinases, as key regulators of cellular signal transduction, play a critical role in fundamental biomedical research, drug development, and clinical translation by detecting their activity.

ALK4 and ActRIIB are a functionally coupled pair of type I and type II transmembrane serine/threonine kinase receptors within the transforming growth factor-beta (TGF-β) superfamily signaling pathway. ActRIIB, as the type II receptor, features an extracellular domain that binds with high affinity to various ligands, including activin, GDF8 (myostatin), and GDF11, and possesses constitutive kinase activity. In contrast, ALK4, as the type I receptor, is strictly dependent on the type II receptor for its activation. Together, in the presence of ligand, they form a stable heterotetrameric signal transduction complex.